The GABAA-BZR Complex as Target for the Development of Anxiolytic Drugs

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|12|4|254-269

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.12, Iss.4, 2012-02, pp. : 254-269

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Developments in Potential Anxiolytic Agents Targeting GABAA/BzR Complex or the Translocator Protein (18kDa) (TSPO)

By  

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 4, 2012-02 ,pp. : 360-370

Bentham Science Publishers

Access to resources Recommend Favorite

Geometrically Constrained Derivatives of Indolylglyoxylamides as Ligands Binding the GABAA/BzR Complex

By  

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 4, 2012-02 ,pp. : 312-320

Bentham Science Publishers

Access to resources Recommend Favorite

Medicinal Chemistry of Indolylglyoxylamide GABAA/BzR High Affinity Ligands: Identification of Novel Anxiolytic/Non Sedative Agents

By  

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 4, 2012-02 ,pp. : 286-311

Bentham Science Publishers

Access to resources Recommend Favorite

The benzodiazepine binding site of GABAA receptors as a target for the development of novel anxiolytics

By Atack John R  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 5, 2005-05 ,pp. : 601-618

Informa Healthcare

Access to resources Recommend Favorite

Heterogeneity of GABAA Receptors: Revived Interest in the Development of Subtype-selective Drugs

By  

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 5, Iss. 3, 2005-09 ,pp. : 217-242

Bentham Science Publishers

Access to resources Recommend Favorite